Jane A Meyer, ARPN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 2707 L St, Ord, NE 68862 Phone: 308-728-4202 Fax: 308-728-3500 |
Johanna Spencer, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 2707 L St, Ord, NE 68862 Phone: 308-728-4202 Fax: 308-728-3500 |
Darian Marie Nordhues, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 2707 L St, Ord, NE 68862 Phone: 308-728-4200 Fax: 308-728-3500 |
Dion Douglas Machard, APRN-NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 2707 L St Ste 1, Ord, NE 68862 Phone: 308-728-4202 Fax: 308-728-3500 |
Jenna A Hilker, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2707 L St, Ord, NE 68862 Phone: 308-728-4200 Fax: 308-728-3500 |
Kelly Ann Geweke, APRN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 2707 L St, Suite 1, Ord, NE 68862 Phone: 308-728-4202 Fax: 308-728-3500 |
Lisa Marie Bruha, Nurse Practitioner - Primary Care Medicare: Medicare Enrolled Practice Location: 46725 809th Rd, Ord, NE 68862 Phone: 308-730-1100 |
News Archive
A wearable, picture-taking health monitor created by University of Pittsburgh researchers has received a recent facelift. Now, in addition to documenting what a person eats, the eButton prototype can accurately match those images against a geometric-shape library, providing a much easier method for counting calories.
Parent Project Muscular Dystrophy (PPMD) has awarded Dr. Craig McDonald of the University of California, Davis (UC Davis) $175,000 in supplemental funds to expand his ongoing study through the 20 CINRG (Cooperative International Neuromuscular Research Group) centers to better understand the progression of Duchenne muscular dystrophy (Duchenne) and determine the impact of the Duchenne standards of care established by the Centers for Disease Control (CDC).
The US Food and Drug Administration has announced that it has approved the drug vemurafenib for the treatment of patients with BRAF V600-mutant Erdheim-Chester disease (ECD).
LifeCycle Pharma A/S (OMX: LCP) announced today that the Board of Directors of LCP and Jim New have agreed to terminate the contract with Jim New. Hence, Jim New will with immediate effect step down as the President and CEO of LCP. The termination is related to different views on how an international company based in Scandinavia shall be managed.
Given Imaging Ltd., the global leader in patient-friendly GI diagnostic and monitoring solutions, today announced three new studies that demonstrate the clinical utility of PillCam SB capsule endoscopy in providing physicians with critical information on how they manage and/or diagnose intestinal disorders. These novel studies were carried out in pediatric patients with gastrointestinal symptoms, including children with known or suspected Crohn's disease.
› Verified 9 days ago